Safe Entry Stations
Mitigate risks to your team and to the uninterrupted operation of your business by setting up Safe Entry Stations for infectious disease symptom detection or for impairment detection. Our screening products for infectious disease and impairment are quick, noninvasive, no-contact solutions that can detect a first look indication of symptoms. All it takes is a simple walk-through.
Our Solutions
Our Partners
Our strategic partners help our team make a significant impact on the health and safety of people around the globe. We currently have partnerships in the US, Canada, and South Asia.










Accurate Detection Without Sacrificing Privacy
With multispectral cameras and sensors all functioning with full autonomy, you can screen quickly and easily all while maintaining privacy as a priority. Safe Entry Stations can also be customized for your location for permanent, temporary, and mobile use.

Recent Press
Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies
Toronto, ON, June 29, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has received a non-binding Letter of Intent (LOI) from KaTron Defence Space and Simulation Technologies, a leading Turkish provider of simulation products […]
Predictmedix Secures Deployment of Safe Entry Stations at De Beers Forevermark Forum 2022
High Visibility, Revenue Generating Deployment Provides Predictmedix with Strong Industry Validation Toronto, ON – June 15, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has secured a revenue-generating deployment at the DeBeers Forevermark Forum […]
Predictmedix Reports Fiscal 2022 Financial Results
TORONTO, ON / ACCESSWIRE / June 1, 2022 /Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today reported its financial and operational results for the fourth quarter and fiscal year ended January 31, 2022. Recent Fiscal 2022 and Subsequent Operational Highlights […]